Skip to main content

Merck & Co., Inc.

corporate_fare Company Profile

Merck & Co., Inc.

MRK·NYSE·Life Sciences·CIK 0000310158

Merck & Co., Inc. is a global healthcare company providing innovative health solutions through prescription medicines, including biologic therapies, vaccines, and animal health products. The company manages its operations primarily on a product basis, with two reportable operating segments: Pharmaceutical and Animal Health. The Pharmaceutical segment encompasses human health pharmaceutical and vaccine products. Human health pharmaceutical products are therapeutic and preventive agents, generally sold by prescription, for treating human disorders. Merck sells these products mainly to drug wholesalers and retailers, hospitals, government agencies, and managed healthcare providers like health maintenance organizations and pharmacy benefit managers. Human health vaccine products include preventive pediatric, adolescent, and adult vaccines, sold primarily to physicians, wholesalers, distributors, and government entities. The Animal Health segment focuses on discovering, developing, manufacturing, and marketing a broad range of veterinary pharmaceutical and vaccine products, alongside health management solutions and services. These offerings aim to prevent, treat, and control diseases in all major livestock and companion animal species. This segment also provides a comprehensive suite of digitally connected identification, traceability, and monitoring products. Merck sells its animal health products to veterinarians, distributors, animal producers, farmers, and pet owners.

Merck & Co., Inc. (NYSE:MRK) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 66 items for MRK at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Merck Finalizes $6 Billion Debt Offering to Repay Terns Acquisition Loan
  • Merck Prices $6.0 Billion Multi-Tranche Debt Offering to Repay Terns Acquisition Financing
  • Merck's Sacituzumab Tirumotecan Trial Hits Key Survival Endpoints in Endometrial Cancer
  • Merck's Keytruda-Moderna Vaccine Trial Advances, Gardasil Litigation Sees Mixed Outcomes
  • Merck Reports Q1 GAAP Net Loss Driven by $9.0B Cidara Acquisition Charge; Updates on Key Products & Pipeline

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$65.01B
Net Income
$18.25B
Diluted EPS
$7.28
Op. Cash Flow
$16.47B
Free Cash Flow
$12.36B
Gross Profit
$48.63B
Cash & Equivalents
$14.56B
Total Debt
$49.05B
Debt / Equity
0.93×
Net Margin
28.1%
Shares Outstanding
2.5B sh
Source: 10-K · filed 2026-02-24 · accession 0000310158-26-000063
$141.73 -0.09% today
52-week range · as of 2026-08-07 $77.58 – $141.73
Market cap
$349.67B
Volume
1.7M (0.2× avg)
3-mo avg 10.2M
Live data · 2026-10-28 15:31 UTC · Market open

show_chartPrice Chart

Loading chart...

feed MRK - Filings & News (Page 3)

MRK
May 20, 2026, 4:23 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $113.25
Real-time Price: $141.73 info
Change: +$28.48 (+25%) info
Market Cap: $349.672B info
MRK
May 18, 2026, 6:41 PM EDT
Filing Type: FWP
Importance Score:
7
Price at Filing: $112.18
Real-time Price: $141.73 info
Change: +$29.55 (+26%) info
Market Cap: $349.672B info
MRK
May 18, 2026, 6:48 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $111.37
Real-time Price: $141.73 info
Change: +$30.36 (+27%) info
Market Cap: $349.672B info
MRK
May 08, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $111.38
Real-time Price: $141.73 info
Change: +$30.35 (+27%) info
Market Cap: $349.672B info
MRK
May 04, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.11
Real-time Price: $141.73 info
Change: +$28.62 (+25%) info
Market Cap: $349.672B info
MRK
Apr 30, 2026, 6:53 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $113.00
Real-time Price: $141.73 info
Change: +$28.73 (+25%) info
Market Cap: $349.672B info
MRK
Apr 30, 2026, 6:30 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $115.00
Real-time Price: $141.73 info
Change: +$26.73 (+23%) info
Market Cap: $349.672B info
MRK
Apr 30, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $112.94
Real-time Price: $141.73 info
Change: +$28.79 (+25%) info
Market Cap: $349.672B info
MRK
Apr 24, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $113.99
Real-time Price: $141.73 info
Change: +$27.74 (+24%) info
Market Cap: $349.672B info
MRK
Apr 21, 2026, 11:50 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $112.55
Real-time Price: $141.73 info
Change: +$29.18 (+26%) info
Market Cap: $349.672B info
MRK
Apr 21, 2026, 6:51 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $116.99
Real-time Price: $141.73 info
Change: +$24.74 (+21%) info
Market Cap: $349.672B info
MRK
Apr 20, 2026, 7:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $118.52
Real-time Price: $141.73 info
Change: +$23.21 (+20%) info
Market Cap: $349.672B info
MRK
Apr 13, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $119.66
Real-time Price: $141.73 info
Change: +$22.07 (+18%) info
Market Cap: $349.672B info
MRK
Apr 08, 2026, 4:25 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $123.49
Real-time Price: $141.73 info
Change: +$18.24 (+15%) info
Market Cap: $349.672B info
MRK
Mar 30, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $118.10
Real-time Price: $141.73 info
Change: +$23.63 (+20%) info
Market Cap: $349.672B info
MRK
Mar 30, 2026, 11:48 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $118.06
Real-time Price: $141.73 info
Change: +$23.67 (+20%) info
Market Cap: $349.672B info
MRK
Mar 29, 2026, 11:49 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $119.27
Real-time Price: $141.73 info
Change: +$22.46 (+19%) info
Market Cap: $349.672B info
MRK
Mar 25, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $116.68
Real-time Price: $141.73 info
Change: +$25.05 (+21%) info
Market Cap: $349.672B info
MRK
Mar 24, 2026, 9:03 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $116.68
Real-time Price: $141.73 info
Change: +$25.05 (+21%) info
Market Cap: $349.672B info
MRK
Mar 05, 2026, 3:04 PM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $115.78
Real-time Price: $141.73 info
Change: +$25.95 (+22%) info
Market Cap: $349.672B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets